IL206110A - A strain of Sacromitacus serbis for treating @ or @ preventing @ intestinal disorders - Google Patents

A strain of Sacromitacus serbis for treating @ or @ preventing @ intestinal disorders

Info

Publication number
IL206110A
IL206110A IL206110A IL20611010A IL206110A IL 206110 A IL206110 A IL 206110A IL 206110 A IL206110 A IL 206110A IL 20611010 A IL20611010 A IL 20611010A IL 206110 A IL206110 A IL 206110A
Authority
IL
Israel
Prior art keywords
prevention
treatment
saccharomyces cerevisiae
cerevisiae strain
intestinal disorders
Prior art date
Application number
IL206110A
Other languages
English (en)
Hebrew (he)
Other versions
IL206110A0 (en
Original Assignee
Univ Lille Ii Droit & Sante
Lesaffre & Cie
Univ Clermont Auvergne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0801342A external-priority patent/FR2928652B1/fr
Application filed by Univ Lille Ii Droit & Sante, Lesaffre & Cie, Univ Clermont Auvergne filed Critical Univ Lille Ii Droit & Sante
Publication of IL206110A0 publication Critical patent/IL206110A0/en
Publication of IL206110A publication Critical patent/IL206110A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • C12N1/18Baker's yeast; Brewer's yeast
    • C12N1/185Saccharomyces isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14Yeasts or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/85Saccharomyces
    • C12R2001/865Saccharomyces cerevisiae

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
IL206110A 2007-12-26 2010-05-31 A strain of Sacromitacus serbis for treating @ or @ preventing @ intestinal disorders IL206110A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0760377 2007-12-26
FR0801342A FR2928652B1 (fr) 2008-03-12 2008-03-12 Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
PCT/FR2008/001729 WO2009103884A2 (fr) 2007-12-26 2008-12-12 Composition pour l'alimentation humaine et/ou animale, ses utilisations, levures

Publications (2)

Publication Number Publication Date
IL206110A0 IL206110A0 (en) 2010-11-30
IL206110A true IL206110A (en) 2013-07-31

Family

ID=40985983

Family Applications (1)

Application Number Title Priority Date Filing Date
IL206110A IL206110A (en) 2007-12-26 2010-05-31 A strain of Sacromitacus serbis for treating @ or @ preventing @ intestinal disorders

Country Status (24)

Country Link
US (1) US8476058B2 (cg-RX-API-DMAC7.html)
EP (1) EP2227539B1 (cg-RX-API-DMAC7.html)
JP (1) JP5497661B2 (cg-RX-API-DMAC7.html)
KR (1) KR101654537B1 (cg-RX-API-DMAC7.html)
CN (1) CN101918536B (cg-RX-API-DMAC7.html)
AU (1) AU2008351156B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0820068B8 (cg-RX-API-DMAC7.html)
CA (1) CA2709850C (cg-RX-API-DMAC7.html)
DK (1) DK2227539T3 (cg-RX-API-DMAC7.html)
ES (1) ES2649914T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20171632T1 (cg-RX-API-DMAC7.html)
HU (1) HUE034628T2 (cg-RX-API-DMAC7.html)
IL (1) IL206110A (cg-RX-API-DMAC7.html)
LT (1) LT2227539T (cg-RX-API-DMAC7.html)
MX (1) MX2010007011A (cg-RX-API-DMAC7.html)
MY (1) MY159379A (cg-RX-API-DMAC7.html)
NO (1) NO2227539T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ586417A (cg-RX-API-DMAC7.html)
PL (1) PL2227539T3 (cg-RX-API-DMAC7.html)
RU (1) RU2490324C2 (cg-RX-API-DMAC7.html)
SI (1) SI2227539T1 (cg-RX-API-DMAC7.html)
TN (1) TN2010000239A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009103884A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201003978B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876798A1 (fr) * 2004-10-14 2006-04-21 Univ Clermont Auvergne Diagnostic et traitement de la maladie de crohn
KR101654537B1 (ko) 2007-12-26 2016-09-06 르샤프르 에 꽁빠니 인간 및/또는 동물 영양을 위한 조성물, 이의 용도 및 효모균
FR2949043B1 (fr) * 2009-08-17 2013-05-17 Lesaffre & Cie Pate boulangere fermentee tolerante a l'appret
KR101933232B1 (ko) * 2011-03-04 2019-03-15 라이온 가부시키가이샤 성장 호르몬 분비 촉진제
ITMI20111488A1 (it) * 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
FR2993179B1 (fr) * 2012-07-13 2016-01-08 Lesaffre & Cie Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales
WO2015061798A2 (en) * 2013-10-25 2015-04-30 R.F. Technology Consultants, Inc. Compositions and methods comprising yeast organisms and lipid extracts thereof
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
KR101837160B1 (ko) 2016-07-20 2018-03-09 서울대학교산학협력단 신균주 bt-sjp kctc12726bp 및 이의 용도
WO2018052082A1 (ja) * 2016-09-14 2018-03-22 株式会社Tesホールディングス Lin28a活性化剤及びその使用
US11523625B2 (en) 2017-08-07 2022-12-13 Techmix, Llc Feed supplement bolus with active yeast
CN109536370A (zh) * 2018-12-10 2019-03-29 浙江华康药业股份有限公司 一种体外发酵糖醇益生功能评价装置及方法
FR3089788B1 (fr) * 2018-12-17 2020-12-18 Lesaffre & Cie Souche de levure Saccharomyces cerevisiae pour le traitement et/ou la prévention de candidoses oropharyngées
FR3090318B1 (fr) 2018-12-19 2024-06-14 Lesaffre & Cie Souche Saccharomyces cerevisiae var boulardii en santé orale
PL3685681T3 (pl) 2019-01-23 2024-10-21 Lesaffre Et Compagnie Produkt drożdżowy i zawierająca go kompozycja do zastosowania jako środek prebiotyczny
FR3096891B1 (fr) 2019-06-04 2022-05-13 Lesaffre & Cie Composition pour la prevention de la cystite simple et/ou recidivante
CN112273657A (zh) * 2019-07-22 2021-01-29 安琪酵母股份有限公司 用于预防或改善过敏性疾病的益生菌组合物、制法和应用
KR102275115B1 (ko) * 2019-10-16 2021-07-07 한국식품연구원 프로바이오틱 활성을 갖는 사카로마이세스 세레비지애 보울라디­03 신균주 및 이의 용도
FR3120789B1 (fr) 2021-03-16 2024-01-19 Lesaffre & Cie Inhibiteurs glycosidiques de levure
CA3223134A1 (en) 2021-06-30 2023-01-05 Carlos DE LECEA Physiologically acceptable yeast compositions for use in the treatment of a gastro-intestinal disorder
CN118354680A (zh) * 2021-06-30 2024-07-16 英联马利(英国)有限公司 用于治疗胃肠障碍的生理学上可接受的酵母菌组合物
FR3134581B1 (fr) * 2022-04-15 2026-02-27 Lesaffre & Cie Levure Saccharomyces cerevisiae et son utilisation pour améliorer la santé intestinale des animaux de compagnie.
WO2025115611A1 (ja) * 2023-11-30 2025-06-05 株式会社日清製粉グループ本社 免疫調節剤
EP4732843A1 (en) 2024-10-22 2026-04-29 Lesaffre et Compagnie Live saccharomyces cerevisiae strains for the treatment of bone-loss disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
RU2233320C2 (ru) * 2001-02-13 2004-07-27 Гриневич Владимир Борисович Способ получения биологически активного препарата, биологически активная добавка (бад) к пище пребиотического действия, приводящая к коррекции (нивелированию) метаболического синдрома и лекарственный препарат для регуляции микробиоценоза желудочно-кишечного тракта
ATE554782T1 (de) 2004-08-23 2012-05-15 Bharat Biotech Int Ltd Synergistische formulierung auf eukaryotischer basis gegen gastrointestinale erkrankungen
US7799328B2 (en) * 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
US7498367B2 (en) * 2005-02-21 2009-03-03 Kerr Corporation Acid-tolerant dental composition
FR2928652B1 (fr) 2008-03-12 2013-11-15 Lesaffre & Cie Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
KR101654537B1 (ko) 2007-12-26 2016-09-06 르샤프르 에 꽁빠니 인간 및/또는 동물 영양을 위한 조성물, 이의 용도 및 효모균

Also Published As

Publication number Publication date
LT2227539T (lt) 2017-11-27
US20100303778A1 (en) 2010-12-02
EP2227539B1 (fr) 2017-08-09
MY159379A (en) 2016-12-30
DK2227539T3 (da) 2017-11-13
US8476058B2 (en) 2013-07-02
RU2010131018A (ru) 2012-02-10
AU2008351156B2 (en) 2013-10-17
SI2227539T1 (en) 2018-03-30
WO2009103884A3 (fr) 2009-12-17
NO2227539T3 (cg-RX-API-DMAC7.html) 2018-01-06
ZA201003978B (en) 2012-02-29
AU2008351156A1 (en) 2009-08-27
IL206110A0 (en) 2010-11-30
BRPI0820068B1 (pt) 2020-03-17
WO2009103884A2 (fr) 2009-08-27
KR101654537B1 (ko) 2016-09-06
CA2709850C (fr) 2018-03-20
JP5497661B2 (ja) 2014-05-21
EP2227539A2 (fr) 2010-09-15
CA2709850A1 (fr) 2009-08-27
TN2010000239A1 (fr) 2011-11-11
JP2011509651A (ja) 2011-03-31
NZ586417A (en) 2012-07-27
HUE034628T2 (hu) 2018-02-28
RU2490324C2 (ru) 2013-08-20
HRP20171632T1 (hr) 2017-12-15
KR20110066118A (ko) 2011-06-16
PL2227539T3 (pl) 2018-01-31
BRPI0820068A2 (pt) 2015-09-01
BRPI0820068B8 (pt) 2021-07-27
CN101918536B (zh) 2013-07-03
MX2010007011A (es) 2010-10-13
CN101918536A (zh) 2010-12-15
ES2649914T3 (es) 2018-01-16

Similar Documents

Publication Publication Date Title
IL206110A (en) A strain of Sacromitacus serbis for treating @ or @ preventing @ intestinal disorders
PL2118074T3 (pl) Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego
EP2440209A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HEART FAILURE
AP2011005637A0 (en) Carbazole compounds and therapeutic uses of the compounds.
IL184312A0 (en) Herbal compositions for the treatment of diabetes and/or conditions associated therewith
AP2010005508A0 (en) Triazole derivatives useful for the treatment of diseases.
IL200766A0 (en) Compositions and methods for the prevention and treatment of autoimmune conditions
IL208455A0 (en) Capsule for the prevention of cardiovascular diseases
WO2011090694A8 (en) Orally administrable film dosage forms containing ondansetron
IL200091A (en) Kittensan to treat infectious diseases of the nail
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
ZA201009171B (en) Dronedarone for the prevention of cardioversion
ZA201005616B (en) The production of titanium trifluoride
EP2480099A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING METABOLIC DISEASES
PL2307380T3 (pl) Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowego
GB0808730D0 (en) Compositions and methods for the prevention and treatment of schistosomiasis
HK1169604A (en) Compositions and methods for the prevention and treatment of heart failure
PL381713A1 (pl) Kompozycja ziołowa spowalniająca proces starzenia się organizmu
GB0602857D0 (en) The treatment of sialorrhoea
GB0809319D0 (en) The treatment of puritus
GB0703787D0 (en) The treatment of fibrotic disorders
GB0700210D0 (en) The treatment of fibrotic disorders
GB0716840D0 (en) Treatment of cardiovascular disease
PL386697A1 (pl) Sposób uwłókniania słomy zbożowej
AU2009902409A0 (en) Method for the treatment of mental disorders

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed